Differences between Istradefylline Responders and Non-Responders in Parkinson’s Disease

Journals Menu

Follow SCIRP

ISSN Print: 2169-9712
ISSN Online: 2169-9720
www.scirp.org/journal/apd
E-mail: apd@scirp.org

"Differences between Istradefylline Responders and Non-Responders in Parkinson’s Disease"
written by Asako Yoritaka, Nobutaka Hattori,
published by Advances in Parkinson's Disease, Vol.6 No.2, 2017

has been cited by the following article(s):

[1]	Development of 18F-labeled radiotracers for PET imaging of the adenosine A2A receptor: Synthesis, radiolabeling and preliminary biological evaluation
	2021

[2]	Synthesis and biological evaluation of a novel 18F-labeled radiotracer for PET imaging of the adenosine A2A receptor
	2021

[3]	Clinical Efficacy of Istradefylline for Depression in Parkinson's Disease
	2018

[1]	Synthesis and Biological Evaluation of a Novel 18F-Labeled Radiotracer for PET Imaging of the Adenosine A2A Receptor International Journal of Molecular Sciences, 2021 DOI:10.3390/ijms22031182

[2]	Development of 18F-Labeled Radiotracers for PET Imaging of the Adenosine A2A Receptor: Synthesis, Radiolabeling and Preliminary Biological Evaluation International Journal of Molecular Sciences, 2021 DOI:10.3390/ijms22052285

[3]	Synthesis and Biological Evaluation of a Novel 18F-Labeled Radiotracer for PET Imaging of the Adenosine A2A Receptor International Journal of Molecular Sciences, 2021 DOI:10.3390/ijms22031182

Follow SCIRP